Six out of ten of the world's best-selling drugs are based on molecules called monoclonal antibodies. But their high impact comes with a low profile. This is a story of how basic science quietly became blockbuster medicine. Originally aired 14/08/13. For information regarding your data privacy, visit acast.com/privacy